<SEC-DOCUMENT>0001437749-25-018342.txt : 20250523
<SEC-HEADER>0001437749-25-018342.hdr.sgml : 20250523
<ACCEPTANCE-DATETIME>20250523161237
ACCESSION NUMBER:		0001437749-25-018342
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250501
FILED AS OF DATE:		20250523
DATE AS OF CHANGE:		20250523

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			De Rosch Mark
		CENTRAL INDEX KEY:			0001890320
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37942
		FILM NUMBER:		25982353

	MAIL ADDRESS:	
		STREET 1:		C/O AURA BIOSCIENCES, INC.
		STREET 2:		85 BOLTON STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02140

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CervoMed Inc.
		CENTRAL INDEX KEY:			0001053691
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				300645032
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		20 PARK PLAZA
		STREET 2:		SUITE 424
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		(617) 744-4400

	MAIL ADDRESS:	
		STREET 1:		20 PARK PLAZA
		STREET 2:		SUITE 424
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Diffusion Pharmaceuticals Inc.
		DATE OF NAME CHANGE:	20160115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RestorGenex Corp
		DATE OF NAME CHANGE:	20140307

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Stratus Media Group, Inc
		DATE OF NAME CHANGE:	20080722
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>rdgdoc.xml
<DESCRIPTION>FORM 3
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2025-05-01</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001053691</issuerCik>
        <issuerName>CervoMed Inc.</issuerName>
        <issuerTradingSymbol>CRVO</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001890320</rptOwnerCik>
            <rptOwnerName>De Rosch Mark</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O CERVOMED INC.</rptOwnerStreet1>
            <rptOwnerStreet2>20 PARK PLAZA, SUITE 424</rptOwnerStreet2>
            <rptOwnerCity>BOSTON</rptOwnerCity>
            <rptOwnerState>MA</rptOwnerState>
            <rptOwnerZipCode>02116</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isOfficer>1</isOfficer>
            <officerTitle>EVP, RA and GA and PgM</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>12.5300</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2034-11-07</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>32000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>2.3000</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2035-02-04</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>27000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Shares granted as an inducement award material to Dr. De Rosch's entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). Award vests in equal monthly installments over thirty-six (36) months on the last day of each month commencing November 30, 2024.</footnote>
        <footnote id="F2">Shares granted under the Issuer's 2015 Equity Incentive Plan, as amended. Award vests in equal monthly installments over thirty-six (36) months on the last day of each month commencing February 28, 2025.</footnote>
    </footnotes>

    <remarks>Exhibit 24.1 &amp;#8211; Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>/s/ William R. Elder, Attorney-in-Fact for Mark De Rosch</signatureName>
        <signatureDate>2025-05-23</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>crvo20250523_sec16.htm
<TEXT>
<html><head>
	<title>crvo20250523_sec16.htm</title>

	<!-- Generated by ThunderDome Portal - 5/23/2025 5:47:11 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 24.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>POWER OF ATTORNEY</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Know all by these presents, that the undersigned hereby constitutes and appoints each of John Alam, M.D., William Elder, Jason McCaffrey, Esq., Gianna Nappi, Esq., Christopher Kinney, Esq., Maura Foley, Robyn Frattali, Autumn Mays, Ruby Rawlinson and Erber Hernandez as the undersigned&#8217;s true and lawful attorneys-in-fact to:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:32pt;">(1) execute for and on behalf of the undersigned, in the undersigned&#8217;s capacity as a reporting person pursuant to Section 16 of the Securities Exchange Act of 1934, as amended (the &#8220;<b>Exchange Act</b>&#8221;), and the rules thereunder of Forms 3, 4 and 5, including any amendments thereto, in accordance with Section 16(a) of the Exchange Act;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:32pt;">(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5, complete and execute any amendment or amendments thereto and timely file such form with the United States Securities and Exchange Commission and the applicable stock exchange or similar authority; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:32pt;">(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of any of such attorneys-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by any of such attorneys-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as any of such attorneys-in-fact may approve in the discretion of any of such attorneys-in-fact.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:32pt;">The undersigned hereby grants to each such attorney-in-fact full power and authority to act separately and to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that any of such attorneys-in-fact, or the substitute or substitutes of any of such attorneys-in-fact, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned&#8217;s responsibilities to comply with Section 16 of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:32pt;">This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned&#8217;s holdings of and transactions in securities issued, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:32pt;">IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 2<sup style="vertical-align:top;line-height:120%;">nd</sup> day of May, 2025.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 50%;"><u>/s/ Mark De Rosch</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>Name: Mark De Rosch, Ph.D., FRAPS</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:95pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:95pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">County/City of: <u>Greene&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</u></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Commonwealth/State of <u>Virginia&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</u></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">I certify this to be a complete, full, true and</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">exact reproduction of the original document</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certified this 2<sup style="vertical-align:top;line-height:120%;">nd</sup> day of May, 2025</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>/s/ Emily Krahn</u></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Notary Public</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">My Commission Expires: <u>/2/28/2029&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</u></p>
			</td>
			<td style="width: 50%; vertical-align: middle;">
			<div style="text-align: center;"><img alt="ekstamp01.jpg" src="ekstamp01.jpg"></div>

			<p style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; margin: 0pt;">&nbsp;</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ekstamp01.jpg
<TEXT>
begin 644 ekstamp01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !E 1D# 2(  A$! Q$!_\0
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M_P!$;^'_ /X2]C_\:H_X9.^"'_1&_A__ .$O8_\ QJ@L/^&L?@A_T63X?_\
MA46/_P =H_X:Q^"'_19/A_\ ^%18_P#QVC_AD[X(?]$;^'__ (2]C_\ &J/^
M&3O@A_T1OX?_ /A+V/\ \:H /^&L?@A_T63X?_\ A46/_P =H_X:Q^"'_19/
MA_\ ^%18_P#QVC_AD[X(?]$;^'__ (2]C_\ &JP/%?P._9H\!I;/XF^'_P *
M/#J7)80-JVBZ9:B4KC<%\Q!NQD9QTR* -_\ X:Q^"'_19/A__P"%18__ !VC
M_AK'X(?]%D^'_P#X5%C_ /':P/"GP._9H\>)<OX9^'_PH\1);%1.VDZ+IET(
MBV=H;RT.W.#C/7!K?_X9.^"'_1&_A_\ ^$O8_P#QJ@ _X:Q^"'_19/A__P"%
M18__ !VC_AK'X(?]%D^'_P#X5%C_ /':R='_ &>OV=/$3(NE?#3X7ZFTEM'>
MH+/0=.E+0.6$<HVQG*,4<!NA*M@\&M;_ (9.^"'_ $1OX?\ _A+V/_QJ@ _X
M:Q^"'_19/A__ .%18_\ QVC_ (:Q^"'_ $63X?\ _A46/_QVJ>H_LS_ #2'L
MUO\ X4_#:R:\G6UMEN/#NGQF>8@D1IF,;G(5B%'.%/I43?LX?L]+KRZ&?A=\
M,QK36YNUTT^']/\ M)A#;3*(_+W;-W&[&,\4 :/_  UC\$/^BR?#_P#\*BQ_
M^.T?\-8_!#_HLGP__P#"HL?_ ([1_P ,G?!#_HC?P_\ _"7L?_C55+3]F3X!
M7]Y>VEM\*/AO<75BZQ74$7AS3V>W=D#JLBB/*DHRL <9# ]#0!;_ .&L?@A_
MT63X?_\ A46/_P =H_X:Q^"'_19/A_\ ^%18_P#QVC_AD[X(?]$;^'__ (2]
MC_\ &J/^&3O@A_T1OX?_ /A+V/\ \:H /^&L?@A_T63X?_\ A46/_P =H_X:
MQ^"'_19/A_\ ^%18_P#QVC_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_
M /A+V/\ \:H /^&L?@A_T63X?_\ A46/_P =H_X:Q^"'_19/A_\ ^%18_P#Q
MVC_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:H /^&L?@A_
MT63X?_\ A46/_P =JI<_M@?!*'5=!TRW^*7A?5]2UW4[?1]/L]$U&/49I;J9
MML2E+<N44MQYCA4!(!89&;?_  R=\$/^B-_#_P#\)>Q_^-5\Z_MB_!#X=?#7
M5?V=]3\(> ?"_A74I?C!X=MI+S1-&MK.9XBT[&,O&BDJ61#MSC*@]A0!]OT4
M44 %?-/PZ97_ &[?B]M(&WPYI*NG()/)W>_'%?2U?-_@<L/VZOB8O!4^&=/;
M(7!ZC@GOTX^IH)9]&C'I61XM\8:+X%T&ZUK7]2M])TJU ,MU<-A1DX '<DD@
M #)).!3?&/B_2? 7AC5/$.NWL>G:1IL#7-S<R'A$4<_4GH!W) K\VOVL/B)K
M'QO^('A+3]"\20I*9)YK6"/5HEL+1EC4O;SQJPWR>0[DR,WS.3''M 8DMI>Q
M$IJ.G4]K^.G[</B#POJS:?IO@CQ#X9\-0ND=]XHU&T5;@L\7F)%:P.&19BI#
M_O\  "@Y45\T>-?CHGCOP.NHZ1=ZAK'BVZ\0Q0OJ>OWUS)I_V0)O$+P.QMU=
MBCAGCA1=@)48.:[KX%_LW>./BM=V_BO1];D?PU=6K[_%6OK(M_J;.B+)## Z
MX$ \J- \@8%01F1214NE_"[QGJ?AN]OM ^#J6/Q EO6E%Q>6,%QY%[:W^VXC
M:XG0)'%<02I(@15C_=ML49Q0Y+H9VE+='AVD^/\ 5F^(.K^*T\,_"FZL?["2
MX&E:A:V<>CV^ZX"KY85.)1DECNW[,$M@ 5W7@_XJ-X=^%Z:S?V-U9>);/Q%)
M$VM^&;F\M]->T4&0H8K26)78*P*N4(V8+ X(/UO<_"WXG7GB_6;RU.F7WAV3
MQ-IVIVUBFL2LZ6:6TBSVK1,3!&JR%!LC4!QRV2*^>?$/P]U'X._#NU\1?%OX
M?PW6M:;IUSJ,NH:)9Q13SZM)=B/3[?[9:J/E2-&9R<@AQNSP*?.WYAR:';_!
MC]N[Q#>^,+;P^VEWWC[3KW<\(,MNFL6AVLWE':L45V"J,R&,9/ +,U?:?@'X
MBZ!\2M';4= OA=1QR&"X@D0QSVLP^]%+&V&1P>""/TKX7^(O[(_C_P )^'[#
MQ+H4W]O+]GANI_LZ.NM:,0&EV62)A/+21V_=PK&S D'/->8_L^>-G^%OBU-1
M;Q8UM?W,,"'7-8EDCMR&91#:21LH5PJN3*H)9 0T; @Y6X<S@TC]7EIU<3\)
M?BEIGQ9\*_VM8-''<P3R65_9+*)&M+F-MLD;$=>>0>ZE3WKMJ#H3OL%%%<UX
MD^)'AGPA>+::OK-M971C$S0L2S)'DCS'"@[$X/S-@<'GB@9TM%1V]Q%=V\4\
M$J302J'CEC8,KJ1D$$<$$=ZDH *\(^.XU5OC+\*%T:?2(+XP:R VMQ/);$>5
M;Y!"LISZ<]J]WK \5_#_ ,+^/$MD\3>&](\1);%C NK6$5T(BV-Q7S%.W.!G
M'7 H \A\8ZGXVTZ+P3II\0:)I-[K7BJ+3KB[\+6H'^B&QNY&4B;S!OW1 JW8
M@<'D'EXO$/C?0M%\4:W-X[U6_B\+>,[30;6SF@M=MY:/=6J2?:6$.YW*73*&
M0ICRT/7<3[SH/PE\#>%IEET7P9X>TB59DN%>PTJ"!A*BNJ2 J@^95EE4'J!(
MX'WCG7D\*:)+;7=N^CZ>]O>7*WMS$UJA2>X5E99G&,,X,:$,>044YX%(#Y&^
M&?B7Q->Z:?%.GW!EU^U^'GA_5IHX8447B1WE])/#L4 #S(PZC:!R1BOHWX5^
M+;GX@WOB/Q)!>--X8EN5LM'C &QTA7$TX.,G?*77J1B($=36O?\ @.WL=&E@
M\)1:7X3U+[-%8PWUOI<;B&W1B5B" IE%WR;5SM4N3@\@Z'@SPEI_@3PII7A[
M2XS'8:=;K;Q ]2 .6/N3DGW)I@>2?M7G61:?"_\ X1Y;-M;/C:T6T.H%A;K(
M;6[ :3;\Q49R0.3C&1G->?\ A_6=1\!>#_'&BW%Z;#XTPZQIO]JZ]<(LKZK;
M7&H0PP7<088^S^6[1B)1B)@R]?F;Z:\02: ^HZ!:ZS%9SWDUZ7TI+J$2,+I(
M9'W19!VNL:RG<,'&[GFLJ./P+\0M:BNA:Z)XBU.SLX+J&[:WCN'CMI9&>%XY
M"#\C26Y8;3UB![ T@/(?B1JWB+3-?O?#&D>+/%NHR:)HBW]W<VHTZT%L9))R
MEQ=7,R@2+B,J(XHN!&2Q)/'E?@7Q%XP\1_#OXL_$RW\87^BZU8Z5INM&WL8+
M?[/=7::%9S.TRO&Q*OMV[%*@ GOC'V#X@^'GA;Q7J=GJ6M>'-*U;4+, 6]W>
MV4<LL0!W *S D#/..F<'K6=%I/@71+R7P?;Z/I%I)K-L6N-)M]/01W,"Q^5^
M^54VE-B>6-_!"[1TQ0!XCXZ\5^-+JV^-OB&P\9ZCHT7@R."\TK3;6"W: M_9
M=M=.DQ>)F=&8L,!AC>WMCZ9L;@W=E;SE=IEC5]H[9&:Y5KKP/=>#-:UUX-*D
M\.:A [ZI</:KY5U'&GDL)E*Y?:D?E[6!.%"XXQ73Z;>VU_9K)9D&!6>(80I@
MHQ1A@@8P5(_"F!:HJMJ6HV^D:?<WUW)Y5K;1M++)M+;549)P,D\#M5F@ HJM
MI^HV^J6YGM9/-B$DD1;:1\R.4<<^C*P_"K- !7RK^WU_S;E_V6;PY_[<5]55
M\J_M]?\ -N7_ &6;PY_[<4 ?55%%% !7S7X3<_\ #>?CL!2JCPK:9<9&\[TP
MI['&21_O&OI2OE[2KX:+^W3X_OI8YUM4\'6\DS%!L(1E8%2.O&X<]Q01+H<7
M^V/\6-'U7Q/:^'-1L]7N]%\-W5GJ&+!'\C4=3%U$HM'*'>RHDN3M! =USR!7
M)?L\?L\6'Q:U.X7Q!:P7^C:3?K)K4AGGF%_?QRRR&V=)@"J,9(I9(R#AHXP?
MF9L<!\6_B;_PD?AC3=%UJPTW5+&QOKGQ!=W.F%I)H;F2 R.C/_JYI/\ 22PC
M1E*^3\V!U^]?V;OAM%\)?@KX4\-HWFW,%DDUY<% K37$G[R5V XR68_D*&D9
M1]^5ST6.!((T2-%CC4!511@*!T '85\P>'_V@W^)_P 4/C3X6N]>M_#'A#P]
MI@L(M3EV0FVN6::-YS*QP>5) ) &SZFOJ1^ /:ORM^/_ ,&-7TCQAX_TK4-.
MT.^DLM L-1N[N*%[IELSJ,QEF"D*R-AP9-BNQ5"%/)HND:SO;0]B_8!N]0?X
MG>,4U>YTG1+FWTFRL_[$TM$MX[[+2/#=B$' _=;2"@&1+\V37VEX.\8:3X\T
MB;4='F-S9QW5Q9,[(5_>PRM%(,'L&0X/?K7P':?&31X=7T+P3I<&D^)=)\33
MR:CHMRDLUI>Z;#';O&86#+YCRQO OV>9N H )&T8^@/^"=GB*VUS]F/1X8_M
M/VZQO+J&^:Y4AGF>4S;P3]X,LJG=W)-'J1!]$?3/E@BOB[]L7]G/PUIUOK_C
MB#3=-M;/5B#K%U)9.SV5P8VB2[1H<. V\>8"2NY8V(^]7VF*R?%GAJP\9>&]
M5T+5($N=.U*VDM+B%QD,CJ5(_6I>VAHU='P#^SU\1=.^$'Q#U%=$TF]U*%M4
M:S\775B##!!:!(8K2_>S9BR.78,\BC:0\F"0HQ^BBG(%?F1\,=5UKX4>,I?!
MNHW<EG8^))$TG6!=64D]U?M;W#VDDD3'*[-C[MZ9(\KD*>3^A7PE\3+XP^&_
MA_55NX[\RVPC>[A(*3.A,;NI'4,R$@^AJNAE3>MF==7E%MJQ^''C?QU-JFB:
MQ?IK5W!?V5[IFF37HFC%K%#]G8Q*WELKQ.1OVKB0'));'J]%!N?.WB2+6!!J
M4=WH?B/P_+)X>M?^$8TOPR\YM[&\"R;H2;<+$LBOY(S,!&4! ^4.*GO?!OB7
M5+C5K^_G\11ZI_PE.F6RFQN[F*(636UFEV8D1@OEDR7.YP."I((9,CZ"HH \
M%N/"6N7^L:!H<S^(QH$/C.\$K+=W08Z?_9L\D:O-NWF SE%&6VYVJ.PK-\$^
M$_%OAZ/PG<V<_B234YKC6[*Z_M:\NIH5@C\]; RI(2B@"*#;(5RVXG+%R3]&
M5R/Q6^(4?PL\#W?B273KG5DM[BUM_L5GS-*9[F* ;!W(,H..^,=Z0'SK>0>+
MI_ DP\-Q^.HO$*^#-1C\0+J7VTEM3\I/(, EX:?SO-*M:_+LQSM\JNT\3^%O
M$'@3Q/XCN?#2>);_ $S2['1]=CMC=W5W]MGCNKI;Z&(NS;I)+4*#$O!;RCMY
M&?2[3XNZ+J.N^&K2SD2XTW7=$NM=AU3S0L4<$#6X.[/3(N0<YXV'-0^(_CIX
M*\.^&I-=_MVSU*PBO;2PD;3[B.4QR7$J)&6PW"X?>3_<4D9XR >&6VB_%\Z+
MX@T^-M:75M/TJZUVRO))'Q+>WMM%BTC9B%<P2G4-J'A<VQ^6KWA^+Q+9Z%XB
M^PMXDOM&ECTR(P-9:K9^3(9R)G7[3)+=']WM\Y85"D8P=YD(^@;;XC>%KS6S
MH\'B#3I=4&__ $1+A3(2@RX SR5') Y Z@4OA_XB^%O%EQ/!HOB'3=5F@C\Z
M5+2Z20HG'S'!Z<CF@#P;PAH.O:GXOT"VO;#69]#M?%EU+!-/:7L"16<NA3(2
MIG9I(XS.[J"7&&?@*2%'#> /AAJG_"L_$US!IWBW2]<T;X?V$&G1(;^SD_M:
M#^T6=8URIF9)#%M4;EQ(-H(<9^J/&/Q!MO#?@:/Q-I\*Z[;W$EG':+;3JJW'
MVF>*&-@_(VYE4Y]*SM)^*6SQ,V@>)M*/AG47@CN+9I+N.>"X5YA"JJZXP_F,
M@"D#.\8SS@ POB#)=2>)]!EUV+Q ?"TFE3B5= %V&2_)C*^:+7]Z/D\P(3\H
M;/1MM9GP@\*:Y;^.K?6O$EMJ(U5_">GPSW5W(Y#3":Y#(^T^69 GE%@.YW?Q
M9/>>*_BGH7A#4=.MKV]MDCN-1.FW,S3JJV<OV1[E1)GNRJ@"]3YJ^M,OOBEI
M<9B>PEMM2LIM(NM7BOH[I%MV2!XD*E^@R9?O=!M.:8'"W7A+51X\N?!2:=<G
MPA?ZM'XGDO1&?LZ1@F26TW]-S7:1R%>Z3/U -4HO"OB#Q#XOT 7TFMVMK9VG
MB.Z5S<W%O;_:1JD)LO.*D!E\O>R(V0R X!4&O9IO%6C6^M)H\NJV4>JN 5LF
MG42G()'RYSD@$@=P#CH:U: /DFYFU8645II)\91^([KP/JTE_!>RW;?:-146
MN)(%8E7?>[8>#*X9 IQ@5Z)X@\,ZX^I^+->A.OMJ=IXMTP:7'#<7(A^Q$:>+
MC9"K;'B(>YWG!'#]"I->J^'_  +X?\*7$D^D:1:Z?*\8AWPI@K&#D1K_ '4S
MSM7 ]JW: /G/68/$%QINE66I6>NB!KO77,QBOY5YU%Q;J8K8JY8Q$&-GD1 G
M(SP1Z[\()]6N/A7X2?7ENTUO^R[=;T7RLL_G",!S(&YW%@2<]377T4 %?*O[
M?7_-N7_99O#G_MQ7U57RK^WU_P VY?\ 99O#G_MQ0!]54444 %?&?Q7NFT[]
MI_XK21NR3O\ #&5T9.2JC>"<8Z@\_A7V97RYXIT4>)/VO?$^AO*ZKJG@5[4*
M5^4[RZ$@CTSSTZT&<]CY&U!=%T)U72=0GUN0'2]&?5(;1S/>6CP-$M_Y\K+M
MA<2F-X4W " D'"YK]5X%6-%1?NJ !7Y0^*KN\\>VWVZQT/2O >LWNBBVN6T^
M2:+S;V*Y,=LDQ<1QQ),(Y '+F)^2264"OTHM?BGHFG?"6Q\=:O>BST0Z=!>7
M%RD;S",,%!XC#$X8XX!H]$3#2]SN6Y%?*_Q$TO3;K]IGXD+J*17-K<?"P^=
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M^,/QKU*REMKO]ENZOK29,26T_C+2'5^?NLK-M/KU(_&N!N=#\?WOBM/$]O\
MLH?V-K\<?DI?6'CZRMGV$ %66/Y&&%7JIX4>@J6[;F3I/HSB#^T?:^ ?B3*=
M%\#V^CZC!;W6EW<"VRQ3P7$]RTMO!]M13:CS&99 K*Q)E)+#:=V_XI\7:U:^
M*=<\/7?B'Q%J221)=_\ "/P6U@MM'93?+<R/]F\L2R*[-@BX1F=E_='J=Y_
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MC_\ &J /5:*\J_X9.^"'_1&_A_\ ^$O8_P#QJC_AD[X(?]$;^'__ (2]C_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
>4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
